Blood levels of flupenthixol in patients with acute and chronic schizophrenia.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 261691)

Published in Ciba Found Symp on January 01, 1979

Authors

E C Johnstone, R C Bourne, P M Cotes, T J Crow, I N Ferrier, F Owen, J D Robinson

Articles by these authors

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24

QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet (2000) 6.78

Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature (1989) 4.69

Experience with human growth hormone in Great Britain: the report of the MRC Working Party. Clin Endocrinol (Oxf) (1979) 4.42

Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet (1986) 4.04

Lithium neurotoxicity at normal therapeutic levels. Br J Psychiatry (1993) 3.76

Prion dementia without characteristic pathology. Lancet (1990) 3.66

Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ (1994) 3.33

The emperors of the schizophrenia polygene have no clothes. Psychol Med (2008) 3.31

Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet (1976) 3.14

Thioridazine and sudden unexplained death in psychiatric in-patients. Br J Psychiatry (2002) 2.69

Further investigation of the predictors of outcome following first schizophrenic episodes. Br J Psychiatry (1990) 2.67

Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet (1999) 2.47

Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype. Mol Psychiatry (2008) 2.38

Anticipation in Huntington's disease is inherited through the male line but may originate in the female. J Med Genet (1988) 2.37

Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study. Br J Psychiatry (2003) 2.31

D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics (1997) 2.28

Antecedents of schizophrenia and affective illness. Obstetric complications. Br J Psychiatry (1995) 2.25

Autobiographical memory in depression: state or trait marker? Br J Psychiatry (1993) 2.24

Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet (1989) 2.11

Molecular pathology of schizophrenia: more than one disease process? Br Med J (1980) 2.11

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol (2008) 2.11

Neuropeptide Y distribution in the rat brain. Science (1983) 2.10

A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet (1998) 2.07

Presenilin-I, presenilin-II, and VLDL-R associations in early onset Alzheimer's disease. Lancet (1997) 2.06

Complications of pregnancy and delivery in relation to psychosis in adult life: data from the British perinatal mortality survey sample. BMJ (1991) 2.03

Diagnosis of Gerstmann-Sträussler syndrome in familial dementia with prion protein gene analysis. Lancet (1989) 1.97

Influenza and schizophrenia. Br J Psychiatry (1996) 1.93

Service provision for people with schizophrenia. II. Role of the general practitioner. Br J Psychiatry (1997) 1.88

Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain (1992) 1.86

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users. Br J Psychiatry (1999) 1.86

Effect of silicon on gastrointestinal absorption of aluminium. Lancet (1993) 1.80

Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand (2001) 1.80

The Northwick Park electroconvulsive therapy trial. Lancet (1981) 1.79

The dementia of dementia praecox. Acta Psychiatr Scand (1978) 1.79

Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases. Lancet (1994) 1.78

The (Na+ + K+)-activated ATPase. Enzymatic and transport properties. Biochim Biophys Acta (1979) 1.76

Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry (1986) 1.74

Prenatal exposure to influenza as a cause of schizophrenia. There are inconsistencies and contradictions in the evidence. Br J Psychiatry (1994) 1.73

Schizophrenic patients discharged from hospital--a follow-up study. Br J Psychiatry (1984) 1.71

Dangerous behaviour preceding first admissions for schizophrenia. Br J Psychiatry (1992) 1.71

The effects of a neuregulin 1 variant on white matter density and integrity. Mol Psychiatry (2007) 1.68

Acetylator status and response to phenelzine in depressed patients. Lancet (1973) 1.67

Aminoacid polymorphism in human prion protein and age at death in inherited prion disease. Lancet (1991) 1.67

Neuropeptide Y distribution in human brain. Nature (1984) 1.66

Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychol Med (1980) 1.66

Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain (1992) 1.66

Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry (2010) 1.63

Determination of ideal body weight for drug dosage calculations. Am J Hosp Pharm (1983) 1.61

The international reference preparation of erythropoietin. Bull World Health Organ (1966) 1.60

The continuum of psychosis and its implication for the structure of the gene. Br J Psychiatry (1986) 1.60

Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia. Biol Psychiatry (2001) 1.59

Adult psychosis, common childhood infections and neurological soft signs in a national birth cohort. Br J Psychiatry (2002) 1.56

New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet (1997) 1.55

A MRI study of ocular hypertelorism in individuals at high risk of developing schizophrenia. Schizophr Res (2001) 1.54

Relapse in chronic depressives on withdrawal of L-tryptophan. Lancet (1990) 1.53

A neuropathological study of vascular factors in late-life depression. J Neurol Neurosurg Psychiatry (2001) 1.53

Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychol Med (2000) 1.52

Codon 129 changes in the prion protein gene in Caucasians. Am J Hum Genet (1990) 1.52

Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand (2013) 1.52

The neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differ. Acta Psychiatr Scand (2009) 1.51

Concordance by sex in sibling pairs with schizophrenia is paternally inherited. Evidence for a pseudoautosomal locus. Br J Psychiatry (1989) 1.50

The interaction of paramagnetic ions and spin labels with lecithin bilayers. Biochim Biophys Acta (1973) 1.49

Who benefits from electroconvulsive therapy? Combined results of the Leicester and Northwick Park trials. Br J Psychiatry (1992) 1.49

Dopamine is a monoamine oxidase B substrate in man. Nature (1977) 1.48

Anomalous asymmetry of fusiform and parahippocampal gyrus gray matter in schizophrenia: A postmortem study. Am J Psychiatry (2000) 1.48

Unsuspected organic disease in chronic schizophrenia demonstrated by computed tomography. J Neurol Neurosurg Psychiatry (1980) 1.48

CNS amyloid proteins in neurodegenerative diseases. Neurology (1988) 1.47

Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet (1978) 1.47

Experimental transmission of an autosomal dominant spongiform encephalopathy: does the infectious agent originate in the human genome? Br Med J (Clin Res Ed) (1985) 1.47

The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain (1999) 1.47

The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol (2012) 1.46

Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept. Br J Psychiatry (2009) 1.45

Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Arch Gen Psychiatry (1982) 1.44

Precursors of psychosis as pointers to the Homo sapiens-specific mate recognition system of language. Br J Psychiatry (1998) 1.43

The two-syndrome concept: origins and current status. Schizophr Bull (1985) 1.42

Prion-protein immunoreactivity in human transmissible dementias. N Engl J Med (1986) 1.42

Urinary chromatographic profiles in schizophrenia. Biol Psychiatry (1990) 1.42

Twin studies of psychosis and the genetics of cerebral asymmetry. Br J Psychiatry (1999) 1.42

Chromosome Workshops 1998: current state of psychiatric linkage. Am J Med Genet (1999) 1.41

Small intestine permeability in schizophrenia. Br J Psychiatry (1989) 1.41

Influenza and schizophrenia. Br J Psychiatry (1997) 1.40

Management of unusually high serum digoxin concentrations. Drug Intell Clin Pharm (1988) 1.39

Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry (1989) 1.38

The Northwick Park Study of first episodes of schizophrenia. I. Presentation of the illness and problems relating to admission. Br J Psychiatry (1986) 1.36